Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn Sells 4,720 Shares

Phreesia, Inc. (NYSE:PHRGet Free Report) SVP Amy Beth Vanduyn sold 4,720 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $128,903.20. Following the transaction, the senior vice president now directly owns 110,309 shares in the company, valued at approximately $3,012,538.79. The trade was a 4.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Amy Beth Vanduyn also recently made the following trade(s):

  • On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $16,295.92.
  • On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
  • On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Price Performance

Shares of PHR opened at $27.26 on Friday. The stock has a market capitalization of $1.58 billion, a P/E ratio of -18.55 and a beta of 0.94. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16. The company has a 50 day moving average of $23.87 and a 200-day moving average of $22.97. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHRGet Free Report) last released its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same period last year, the business earned ($0.58) earnings per share. The firm’s revenue was up 16.6% on a year-over-year basis. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several hedge funds have recently added to or reduced their stakes in PHR. R Squared Ltd acquired a new stake in Phreesia during the 4th quarter valued at $30,000. International Assets Investment Management LLC lifted its holdings in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia during the second quarter worth $202,000. Point72 DIFC Ltd acquired a new stake in shares of Phreesia during the second quarter worth $209,000. Finally, XTX Topco Ltd acquired a new stake in shares of Phreesia during the third quarter worth $247,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent analyst reports. Robert W. Baird dropped their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. KeyCorp boosted their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Truist Financial boosted their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $31.00.

Check Out Our Latest Stock Analysis on PHR

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

See Also

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.